1 Centre de Dépistage et de Traitement des Tumeurs Digestives, CHU de Rouen, 76031 Rouen, France some p53 mutations selectively impaired the transactivation of bax and therefore the apoptotic function of p53 (12-14), 2 To whom correspondence should be addressed at INSERM EPI 9906,  indicating that some p53 mutations may have a differential In northwestern France, esophagus cancer has a high incidence and is attributable to the consumption of alcoholic Somatic mutations of the tumor suppressor gene p53 have beverages and to tobacco smoking. The incidence of p53 been frequently detected in esophagal cancers, but their mutations had previously been shown to be particularly high biological significance remains to be established. The tumor in esophageal cancers (1, (15) (16) (17) (18) (19) (20) , which suggests that p53 suppressor activity of p53 results in part from its ability inactivation is a key event in esophagus carcinogenesis. Using to transactivate genes involved in the cell cycle and functional assays developed in yeast, we characterized in this apoptosis, such as p21, bax and PIG3, and some p53 study the biological effects of p53 mutations in these tumors. mutations may have a differential effect on the transactivation of these target genes. We developed yeast strains in which the activation by wild-type p53 of reporter plasmids Materials and methods containing p53 binding sites present within these target 
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283 His mutant, indicating that the phenotypes of these mutants were (p21 ϩ / PIG3 ϩ /bax -) and (p21 ϩ /PIG3 -/bax -), respectively. mRNA extraction from bax -) and 175 Leu (p21 ϩ /PIG3 ϩ /bax -). All the tumors yielded in these strains a percentage of red colonies Ͼ10%, indicating that they contain only (p21 -/PIG3 -/bax -) mutants. To determine we show that these mutations abolish the ability of p53 to the mutational spectrum in our series of esophageal tumors, activate p21, bax and PIG3 reporter plasmids. The percentage we sequenced p53 between codons 53 (exon 4) and 364 (exon of p53 mutations in esophagal cancers that we report in this 10) in the 47 positive samples. This analysis, performed either study (84%) is the highest reported with that reported by directly on the RT-PCR product (when the percentage of red Audrezet et al. (16), who had analyzed exons 2-8 of p53 colonies was Ͼ50%) or on plasmids rescued from red colonies, using DGGE. It should be noted that patients analyzed in both identified a p53 mutation in all the samples (Table I) . studies originated from the West part of France (Normandy and Brittany, respectively) where esophagus cancer has a high Discussion incidence. In p53 functional assays, the percentage of red colonies derived from a tumor reflects the inactivation of one Using functional assays in yeast, we confirmed the high frequency of somatic p53 alterations in esophagal cancers and or both alleles and depends on the presence of normal cells in colorectal cancers (1,2).
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The most significant result emerging from this study is p21 site than for the bax site (14, 24, 25) or the RGC site (14).
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retained the ability to transactivate high affinity targets, such 
